Ionis Pharmaceuticals Inc
Company Profile
Business description
Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, and rare diseases. Ionis and partner Biogen brought Spinraza to market in 2016 as a treatment for a rare neuromuscular disorder, spinal muscular atrophy, and Biogen launched ALS drug Qalsody in 2023. Ionis brought two additional drugs to market via its cardiovascular-focused subsidiary Akcea, including ATTR amyloidosis drug Tegsedi (2018) and cardiology drug Waylivra (Europe, 2019).
Contact
2855 Gazelle Court
Carlsbad CA 92010
USAT: +1 760 931-9200
E: WWalke@ionisph.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2024
Employees
927
Ionis Pharmaceuticals Inc News & Analysis
stocks
Global healthcare stocks for your watchlist
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,022.70 | 28.50 | 0.36% |
| CAC 40 | 8,239.43 | 51.78 | 0.63% |
| DAX 40 | 18,789.13 | 102.53 | 0.55% |
| Dow JONES (US) | 39,387.76 | 331.37 | 0.85% |
| FTSE 100 | 8,445.33 | 63.98 | 0.76% |
| HKSE | 18,963.68 | 425.87 | 2.30% |
| NASDAQ | 16,346.26 | 43.51 | 0.27% |
| Nikkei 225 | 38,229.11 | 155.13 | 0.41% |
| NZX 50 Index | 11,755.17 | 8.59 | 0.07% |
| S&P 500 | 5,214.08 | 0.00 | 0.00% |
| S&P/ASX 200 | 7,749.00 | 27.40 | 0.35% |
| SSE Composite Index | 3,154.55 | 0.23 | 0.01% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Sayona Mining Ltd SYA | 0.04 | 0.00 | 10.00% |
| Imugene Ltd IMU | 0.08 | 0.01 | 7.14% |
| Jupiter Mines Ltd JMS | 0.33 | 0.04 | 11.86% |
| Core Lithium Ltd CXO | 0.15 | 0.01 | 3.45% |
| De Grey Mining Ltd DEG | 1.23 | 0.02 | -1.33% |
| Telstra Group Ltd TLS | 3.66 | 0.02 | 0.55% |
| Lake Resources NL LKE | 0.07 | 0.00 | 4.84% |
| Liontown Resources Ltd LTR | 1.40 | 0.00 | 0.00% |
| Pilbara Minerals Ltd PLS | 4.14 | 0.03 | -0.72% |
| Base Resources Ltd BSE | 0.26 | 0.01 | 4.08% |